Comprehensive II
- 646.804
- +8.153+1.28%
On September 10, 11 companies, including Tiantan Biology and China Satcom, announced positive results.
1. Tiantan Biology: Chengdu Rongsheng related production site has passed the drug GMP compliance test Tiantan Biological announcement, Chengdu Rongsheng developed "Human Coagulation Factor Ⅷ" meets the relevant requirements of drug registration. At the same time, Chengdu Rongsheng related production sites have passed the drug GMP compliance inspection, and obtained the "Drug GMP on-the-spot Inspection result notice" issued by the Sichuan Provincial Drug Administration. two。 China Satcom: China Star 9B satellite will be delivered to the company after passing the in-orbit test. China Satcom announced that the China Star 9B satellite launched on September 9 will be delivered to the company's operation management after passing the in-orbit test.
East Sunshine strongly pulls up the daily limit, and northward funds enter the market to buy 109 million yuan.
Securities Star data Center News, according to the trading public information released by the Shanghai and Shenzhen Stock Exchange on September 3, 2021, Dongguang (600673) was on the Dragon and Tiger list because of securities with a deviation of 7%. This is the second time in the last five trading days that it has been on the list. By the end of the day, East Sunshine closed at 9.64 yuan, an increase of 10.05%, with a turnover of 1.5849 million lots. Judging from the day-to-day trading data announced by the Dragon and Tiger list, the institutions totaled a net sale of-30.1609 million yuan. Shanghai Stock Exchange bought 109.6256 million yuan, sold 48.6252 million yuan, and bought a net 6100.04 yuan.
Analysis of the limit of East Sunshine on September 3: innovative drugs, Medicine, Avian Influenza concept Hot stocks
Securities Star data Center News, East Sunshine rose the limit to close, closing price 9.64 yuan. The stock rose by the limit at 09:45, opened the limit five times, and closed its closing order with a capital of 104 million yuan, accounting for 0.36% of its current market value. In terms of capital flow data, the net inflow of main funds on the same day was 200 million yuan, the net inflow of hot capital was 259 million yuan, and the net outflow of retail funds was 65.9267 million yuan. The capital flow in the past five days is shown in the following table: the stock is a hot stock of innovative drugs, pharmaceuticals and bird flu concepts. On the same day, innovative drug concepts rose 1.49%, medicine concepts rose 1.38%, and bird flu concepts rose 1.11%.